| Name | Title | Contact Details |
|---|---|---|
Deb Silvers |
Vice President of Corporate Compliance and General Counsel | Profile |
Behavioral Medicine Associates is a Mount Pleasant, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Edwards Lifesciences (NYSE: EW) is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. Headquartered in Irvine, California, Edwards Lifesciences has extensive operations in North America, Europe, Japan, Latin America and Asia and currently employs 11,000+ individuals worldwide. For us, helping patients is not a slogan ¬ it`s our life¹s work. From developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life. Joining Edwards Lifesciences means innovating, pushing boundaries and being creative while always putting patients first. It means solving challenges with colleagues who share your sense of urgency, optimism, and enthusiasm, colleagues who are just as focused on testing their limits and taking ownership. And it means that you will be empowered to get the job done by taking charge of your work, your health, and your career.
Contego Medical, founded in 2005, has developed a family of novel emboli protection devices. The main feature of each device is that the treatment portion (i.e., balloon or stent) is on the same catheter as the embolic protection device, thus coupling the two together. This device can act as an angioplasty balloon with an integrated emboli protection device. If a stent is mounted on the balloon, it can serve as a stent with an integrated emboli protection device. We know that embolization occurs with all angioplasty and stenting procedures. It is usually hard to predict which ones will result in clinical sequalae. Despite knowing that embolization is ubiquitous, embolic protection devices are not used in all procedures as they add complexity, time, and cost. Dedicated devices do not exist for renal intervention, although the majority of physicians say they would use one if it existed. Contego Medical’s family of embolic protection devices represent a paradigm shift in the treatment of cardiovascular disease.
We are dedicated to investing in highly innovative, early stage biotechnology companies. We are focused on supporting the development of novel therapeutics for unmet medical needs.
Amulet Pharmaceutical is a Halethorpe, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.